In a study of children with symptomatic or asymptomatic C. diff, symptom status loomed as the strongest association with differences in gut microbial abundance and diversity.

Vanderbilt Institute for Global Health researchers, in collaboration with Ugandan partners, have received a $2.5 million grant from the Henry M. Jackson Foundation for the Advancement of Military Medicine to study bunyavirus immunity and long-term complications. Paul Blair, MD, MSPH (Infectious Diseases), is a co-investigator of the study.

The collaboration will leverage VUMC’s resource platform, including its comprehensive datasets hosted in Vanderbilt’s BioVU collection of DNA and plasma to enable data-driven insights and to accelerate discovery and development.

Hematologists with Vanderbilt-Ingram Cancer Center have published strategies for implementing outpatient treatment programs for bispecific antibodies, an immunotherapy that can cause adverse reactions.

The Vanderbilt Transplant Center (VTC) performed 960 solid organ transplants in 2025, the most ever completed by a single center in one year in the United States.

In a study led by Danxia Yu, PhD (Diabetes, Endocrinology and Metabolism), it was found that new weight loss drugs and bariatric surgery improve body composition in patients with obesity by inducing a moderate loss of fat-free mass along with a substantial reduction in fat.

According to a study published last week in JAMA Oncology by Alex Bick, MD, PhD (Genetic Medicine) and colleagues, patients who have been diagnosed with clonal hematopoiesis of indeterminate potential (CHIP) are at an increased risk for heart disease following cancer treatment.